About this trial
Randomized clinical trial. Patients with chronic obstructive pulmonary disease (COPD) GOLD III or IV will undergo 16 sessions of Whole-body Electrical Stimulation (WB-EMS) or pulmonary rehabilitation (PR), twice a week. WB-EMS will be performed in association with squats, biceps and triceps exercises, climbing up and down a step, and abdominal exercises. There will be a progression in the number of muscle contractions after the fourth (from 64 to 96) and tenth sessions (96 to 120). PR will consist of upper and lower limb strengthening exercises. Both groups will perform aerobic exercise (essential component of the pulmonary rehabilitation program). Peripheral muscle strength (dynamometry), respiratory muscle strength (maximum inspiratory and expiratory pressure), muscle thickness (ultrasound), functional capacity (6MWT), quality of life (Saint George's Respiratory Questionnaire), inflammatory profile (PCR, IL-6 e IL-10, TNFα), oxidative stress (protein oxidation, superoxide dismutase and catalase, total hydrogen sulfides, dichlorofluorescein diacetate) will be assessed before and after the 16 sessions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of COPD GOLD 3 and 4;
Age between 18 and 80 years;
Ability to ambulate.
Disqualifiers
Cognitive dysfunction that prevents assessments from being carried out, as well as inability to understand and sign the informed consent form (ICF);
Intolerance to the electrostimulator and/or change in skin sensitivity;
Patients with stroke sequelae;
Recent acute myocardial infarction (two months);
Trial design
Parallel
Treatments tested in this trial
Whole-body electrical stimulation
Other interventionPerformed using Miha Bodytec equipment, properly calibrated, with electrodes on the quadriceps, hamstrings, glutes, biceps, triceps, pectorals, abdomen, trapezius, latissimus dorsi and quadratus lumborum muscles.
Rehabilitation
Other interventionPulmonary rehabilitation program.
Treatment groups
Trial outcomes
Primary outcomes
Peripheral muscle strength
Peripheral muscle strength will be assessed by maximum isometric strength of the knee extensor, elbow flexor and palmar flexor muscles using a hand-held dynamometer
Peripheral muscle strength
Peripheral muscle strength will be assessed by maximum isometric strength of the knee extensor, elbow flexor and palmar flexor muscles using a hand-held dynamometer
Secondary outcomes
Maximum inspiratory pressure
Maximum inspiratory pressure will be assessed by manovacuometry.
Maximum inspiratory pressure
Maximum inspiratory pressure will be assessed by manovacuometry.
Maximum expiratory pressure
Maximum expiratory pressure will be assessed by manovacuometry.
Maximum expiratory pressure
Maximum expiratory pressure will be assessed by manovacuometry.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Federal University of Health Science of Porto Alegre
Lead sponsor
Santa Casa de Porto Alegre
Collaborator
This trial is not recruiting at the moment. You can still explore other options: